SRDX News and Press, Surmodics Inc. From 08/15/23

NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subje...

2023-08-14 08:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences: The Needham Virtual MedTech & Diagnostics 1x1 Conference...

2023-08-06 09:00:43 ET Surmodics, Inc. (SRDX) Q3 2023 Earnings Conference Call August 2, 2023 08:00 ET Company Participants Gary Maharaj - President & Chief Executive Officer Timothy Arens - Chief Financial Officer Conference Call Participants Brooks ...

2023-08-02 09:05:47 ET Surmodics press release ( NASDAQ: SRDX ): Q3 Non-GAAP EPS of $0.52 beats by $0.98 . Revenue of $52.5M (+110.8% Y/Y) beats by $14.44M . For further details see: Surmodics Non-GAAP EPS of $0.52 beats by $0.98, revenue of $52.5M beats ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending September 30, 2023. ...

Earnings Conference Call and Webcast Will Begin at 7:00 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that third quarter of fiscal year 2023 financial results will be releas...

2023-06-23 10:27:12 ET Shares of Surmodics (NASDAQ: SRDX) were up by 24.1% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence . The medical device company's stock closed last week at $25.08, then rose to as high as $32.04 on Wedne...

2023-06-22 16:37:26 ET Summary In November 2020, I rated Surmodics as "one for the future". The "future" has arrived, and there are now several catalysts driving SRDX's prospects higher, discussed in detail in this report. Based on the latest investment findings, I reiterate t...

Surmodics to receive $27 million milestone payment from Abbott Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the receipt of U.S. Food and Drug Administration (FDA) approval for the Su...